Liver Cancer Tumors Appear to Be Resistant to Immunotherapy in...

Immunotherapy is not only significantly less effective in liver cancer patients who previously had a liver disease called non-alcoholic steatohepatitis (NASH), but actually appears to fuel tumor...(PRWeb March 24, 2021)Read the full story at https://www.prweb.com/releases/liver_cancer_tumors_appear_to_be_resistant_to_immunotherapy_in_patients_with_underlying_non_alcoholic_steatohepatitis_nash/prweb17814281.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news